Adenoviridae

From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search

"ad5", "ad26", "ad35", and "ad48" redirect here. For the years, see AD 5, AD 26, AD 35, and AD 48. For other uses, see AD-5 (disambiguation), AD26 (disambiguation), and AD 35 (disambiguation).

Adenoviruses

Transmission electron micrograph of two adenovirus particles

Virus classification

(unranked):

Virus

Realm:

Varidnaviria

Kingdom:

Bamfordvirae

Phylum:

Preplasmiviricota

Class:

Tectiliviricetes

Order:

Rowavirales

Family:

Adenoviridae

Genera

Atadenovirus

Aviadenovirus

Ichtadenovirus

Mastadenovirus

Siadenovirus

Adenoviruses (members of the family Adenoviridae) are medium-sized (90–100 nm), nonenveloped (without an outer lipid bilayer) viruses with an icosahedral nucleocapsid containing a double stranded DNA genome.[1] Their name derives from their initial isolation from human adenoids in 1953.[2]

They have a broad range of vertebrate hosts; in humans, more than 50 distinct adenoviral serotypes have been found to cause a wide range of illnesses, from mild respiratory infections in young children (known as the common cold) to life-threatening multi-organ disease in people with a weakened immune system.[1]

Contents

1 Virology

1.1 Classification

1.2 Diversity

1.3 Structure

1.4 Genome

1.5 Replication

1.6 Multiplicity reactivation

2 Epidemiology

2.1 Transmission

2.2 Humans

2.3 Animals

3 Prevention

4 Diagnosis

5 Infections

6 Treatment

7 Use in gene therapy and vaccination

7.1 Gene therapy

7.2 Vaccines

8 See also

9 References

10 External links

Virology[edit]

Classification[edit]

This family contains the following genera:[1]

Genus Atadenovirus; type species: Ovine atadenovirus D

Genus Aviadenovirus; type species: Fowl aviadenovirus A

Genus Ichtadenovirus; type species: Sturgeon ichtadenovirus A

Genus Mastadenovirus (including all human adenoviruses); type species: Human mastadenovirus C

Genus Siadenovirus; type species: Frog siadenovirus A

Diversity[edit]

It has been suggested that this section be merged into Mastadenovirus. (Discuss) Proposed since December 2020.

Classification of Adenoviridae can be complex.

In humans, currently there are 88 human adenoviruses (HAdVs) in seven species (Human adenovirus A to G):[3]

A: 12, 18, 31

B: 3, 7, 11, 14, 16, 21, 34, 35, 50, 55

C: 1, 2, 5, 6, 57[4]

D: 8, 9, 10, 13, 15, 17, 19, 20, 22, 23, 24, 25, 26, 27, 28, 29, 30, 32, 33, 36, 37, 38, 39, 42, 43, 44, 45, 46, 47, 48, 49, 51, 53, 54, 56,[5] 58, 59, 60, 62, 63,[6] 64, 65, 67, 69,[7] 70, 71, 72, 73, 74, 75

E: 4

F: 40, 41

G: 52[8]

Different types/serotypes are associated with different conditions:[9]

respiratory disease (mainly species HAdV-B and C)

conjunctivitis (HAdV-B and D)

gastroenteritis (HAdV-F types 40, 41, HAdV-G type 52)

obesity or adipogenesis (HAdV-A type 31, HAdV-C type 5, HAdV-D types 9, 36, 37) [10]

All these types are called Human mastadenovirus A–G by the ICTV, because all are members of the genus Mastadenovirus.

When not restricting the subject to human viruses, Adenoviridae can be divided into five genera: Mastadenovirus, Aviadenovirus, Atadenovirus, Siadenovirus, and Ichtadenovirus.[11]

Structure[edit]

Adenoviruses represent the largest known non-enveloped viruses.[1] They are able to be transported through the endosome (i.e., envelope fusion is not necessary). The virion also has a unique "spike" or fiber associated with each penton base of the capsid (see picture below) that aids in attachment to the host cell via the receptor on the surface of the host cell. (See Replication Section below for discussion of diverse receptors.)

In 2010, scientists announced that they had solved the structure of the human adenovirus at the atomic level, making the largest high-resolution model ever. The virus is composed of around 1 million amino acid residues and weighs around 150 MDa.[12][13]

Genome[edit]

Main article: Adenovirus genome

Schematic diagram of the linear adenovirus genome, showing Early genes (E) and Late genes (L).

The adenovirus genome is linear, non-segmented double-stranded (ds) DNA that is between 26 and 48 Kbp.[1] This allows the virus to theoretically carry 22 to 40 genes. Although this is significantly larger than other viruses in its Baltimore group, it is still a very simple virus and is heavily reliant on the host cell for survival and replication. An interesting feature of this viral genome is that it has a terminal 55 kDa protein associated with each of the 5' ends of the linear dsDNA. These are used as primers in viral replication and ensure that the ends of the virus' linear genome are adequately replicated.

Replication[edit]

Adenoviruses possess a linear dsDNA genome and are able to replicate in the nucleus of vertebrate cells using the host's replication machinery.[1]

The structure of adenovirus. 1 = penton capsomeres, 2 = hexon capsomeres, and 3= viral genome (linear dsDNA)

Entry of adenoviruses into the host cell involves two sets of interactions between the virus and the host cell.[1] Most of the action occurs at the vertices. Entry into the host cell is initiated by the knob domain of the fiber protein binding to the cell receptor.[1] The two currently established receptors are: CD46 for the group B human adenovirus serotypes and the coxsackievirus/adenovirus receptor (CAR) for all other serotypes.[1] There are some reports suggesting MHC molecules and sialic acid residues functioning in this capacity as well. This is followed by a secondary interaction, where a motif in the penton base protein (see capsomere) interacts with an integrin molecule. It is the co-receptor interaction that stimulates entry of the adenovirus. This co-receptor molecule is αv integrin. Binding to αv integrin results in endocytosis of the virus particle via clathrin-coated pits. Attachment to αv integrin stimulates cell signaling and thus induces actin polymerization, which facilitates clathrin-mediated endocytosis, and results in virion's entry into the host cell within an endosome.[14]

Once the virus has successfully gained entry into the host cell, the endosome acidifies, which alters virus topology by causing capsid components to disband. The capsid is destabilized and protein VI[non sequitur] is released from the capsid.[15] These changes, as well as the toxic nature of the pentons, destroy the endosome, resulting in the movement of the virion into the cytoplasm.[1] With the help of cellular microtubules, the virus is transported to the nuclear pore complex, whereby the adenovirus particle disassembles. Viral DNA is subsequently released, which can enter the nucleus via the nuclear pore.[16] After this the DNA associates with histone molecules.[clarification needed] Then, viral gene expression can occur, without integrating the viral genome into host cell chromosomes,[17] and new virus particles can be generated.

The adenovirus life cycle is separated by the DNA replication process into two phases: an early and a late phase.[1] In both phases, a primary transcript that is alternatively spliced to generate monocistronic mRNAs compatible with the host's ribosome is generated, allowing for the products to be translated.

The early genes are responsible for expressing mainly non-structural, regulatory proteins.[1] The goal of these proteins is threefold: to alter the expression of host proteins that are necessary for DNA synthesis; to activate other virus genes (such as the virus-encoded DNA polymerase); and to avoid premature death of the infected cell by the host-immune defenses (blockage of apoptosis, blockage of interferon activity, and blockage of MHC class I translocation and expression).

Some adenoviruses under specialized conditions can transform cells using their early gene products. E1A (binds Retinoblastoma tumor suppressor protein) has been found to immortalize primary cells in vitro allowing E1B (binds p53 tumor suppressor) to assist and stably transform the cells. Nevertheless, they are reliant upon each other to successfully transform the host cell and form tumors.

DNA replication separates the early and late phases. Once the early genes have liberated adequate virus proteins, replication machinery, and replication substrates, replication of the adenovirus genome can occur. A terminal protein that is covalently bound to the 5’ end of the adenovirus genome acts as a primer for replication. The viral DNA polymerase then uses a strand displacement mechanism, as opposed to the conventional Okazaki fragments used in mammalian DNA replication, to replicate the genome.

The late phase of the adenovirus lifecycle is focused on producing sufficient quantities of structural protein to pack all the genetic material produced by DNA replication.[1] Once the viral components have successfully been replicated, the virus is assembled into its protein shells and released from the cell as a result of virally induced cell lysis.[1]

Multiplicity reactivation[edit]

Adenovirus is capable of multiplicity reactivation (MR)[18] (Yamamoto and Shimojo, 1971). MR is the process by which two, or more, virus genomes containing lethal damage interact within the infected cell to form a viable virus genome. Such MR was demonstrated for adenovirus 12 after virions were irradiated with UV light and allowed to undergo multiple infection of host cells.[18] In a review, numerous examples of MR in different viruses were described, and it was suggested that MR is a common form of sexual interaction that provides the survival advantage of recombinational repair of genome damages.[19]

Epidemiology[edit]

Transmission[edit]

Adenoviruses are unusually stable to chemical or physical agents and adverse pH conditions, allowing for prolonged survival outside of the body and water. Adenoviruses are spread primarily via respiratory droplets, however they can also be spread by fecal routes. Research into the molecular mechanisms underlying adenoviral transmission provide empirical evidence in support of the hypothesis that coxsackievirus/adenovirus receptors (CARs) are needed to transport adenoviruses into certain naive/progenitor cell types.[20]

Humans[edit]

Main article: Adenovirus infection

Humans infected with adenoviruses display a wide range of responses, from no symptoms at all to the severe infections typical of Adenovirus serotype 14.

Animals[edit]

See also: DA2PPC Vaccine

Bat adenovirus TJM (Bt-AdV-TJM) is a novel species of the Mastadenovirus genus isolated from Myotis and Scotophilus kuhlii in China.[21] It is most closely related to the tree shrew and canine AdVs.[22]

Two types of canine adenoviruses are well known, type 1 and 2. Type 1 (CAdV-1) causes infectious canine hepatitis, a potentially fatal disease involving vasculitis and hepatitis. Type 1 infection can also cause respiratory and eye infections. CAdV-1 also affects foxes (Vulpes vulpes and Vulpes lagopus) and may cause hepatitis and encephalitis. Canine adenovirus 2 (CAdV-2) is one of the potential causes of kennel cough. Core vaccines for dogs include attenuated live CAdV-2, which produces immunity to CAdV-1 and CAdV-2. CAdV-1 was initially used in a vaccine for dogs, but corneal edema was a common complication.[23]

Squirrel adenovirus (SqAdV) is reported to cause enteritis in red squirrels in Europe, while gray squirrels seem to be resistant. SqAdV is most closely related to the adenovirus of guinea pigs (GpAdV).

Adenovirus in reptiles is poorly understood, but research is currently in progress.

Adenoviruses are also known to cause respiratory infections in horses, cattle, pigs, sheep, and goats. Equine adenovirus 1 can also cause fatal disease in immunocompromised Arabian foals, involving pneumonia and destruction of pancreatic and salivary gland tissue.[23] Tupaia adenovirus (TAV) (tree shrew adenovirus 1) has been isolated from tree shrews.

Otarine adenovirus 1 has been isolated from sea lions (Zalophus californianus).[24]

The fowl adenoviruses are associated with many disease conditions in domestic fowl like inclusion body hepatitis, hydropericardium syndrome,[25] Egg drop syndrome, Quail bronchitis, Gizzard erosions and many respiratory conditions. They have also been isolated from wild black kites (Milvus migrans).[26]

Titi monkey adenovirus was isolated from a colony of monkeys.[27]

Prevention[edit]

Main article: Adenovirus vaccine

Currently, there is a vaccine for adenovirus type 4 and 7 for US military personnel only. US military personnel are the recipients of this vaccine because they may be at a higher risk of infection.[citation needed] The vaccine contains a live virus, which may be shed in stool and lead to transmission. There is currently no adenovirus vaccine for the general public. The vaccine is not approved for use outside of the military, as it has not been tested in studied in the general population or on people with weakened immune systems.[28]

In the past, US military recruits were vaccinated against two serotypes of adenovirus, with a corresponding decrease in illnesses caused by those serotypes. That vaccine is no longer manufactured. The U.S. Army Medical Research and Materiel Command announced on 31 October 2011 that a new adenovirus vaccine, which replaces the older version that has been out of production for over a decade, was shipped to basic training sites on 18 October 2011. More information is available here.[29]

Prevention of adenovirus, as well as other respiratory illnesses, involves frequent hand washing for more than 20 seconds, avoiding touching the eyes, face, and nose with unwashed hands, and avoiding close contact with people with symptomatic adenovirus infection. Those with symptomatic adenovirus infection are additionally advised to cough or sneeze into the arm or elbow instead of the hand, to avoid sharing cups and eating utensils, and to refrain from kissing others. Chlorination of swimming pools can prevent outbreaks of conjunctivitis caused by adenovirus.[28]

Diagnosis[edit]

Diagnosis is from symptoms and history. Tests are only necessary in very serious cases. Tests include blood tests, eyes, nose or throat swabs, stool sample tests, and chest x-rays.[30][permanent dead link] In the laboratory, adenovirus can be identified with antigen detection, polymerase chain reaction (PCR), virus isolation and serology. Even if adenovirus is found to be present, it may not be the cause of any symptoms. Some immunocompromised individuals can shed the virus for weeks and show no symptoms.[31]

Infections[edit]

Main article: Adenovirus infection

Most infections with adenovirus result in infections of the upper respiratory tract. Adenovirus infections often present as conjunctivitis, tonsillitis (which may look exactly like strep throat and cannot be distinguished from strep except by throat culture), an ear infection, or croup. Adenoviruses types 40 and 41 can also cause gastroenteritis.[32] A combination of conjunctivitis and tonsillitis is particularly common with adenovirus infections.

Some children (especially the youngest) can develop adenovirus bronchiolitis or pneumonia, both of which can be severe. In babies, adenoviruses can also cause coughing fits that look almost exactly like whooping cough. Adenoviruses can also cause viral meningitis or encephalitis. Rarely, adenovirus can cause hemorrhagic cystitis (inflammation of the urinary bladder—a form of urinary tract infection—with blood in the urine).

Most people recover from adenovirus infections by themselves, but people with immunodeficiency sometimes die of adenovirus infections, and—rarely—even previously healthy people can die of these infections.[33] This may be because sometimes adenoviral infection can lead to cardiac disorders. For example, in one study, some cardiac samples of patients with dilated cardiomyopathy were positive for presence of adenovirus type 8.[34]

Adenoviruses are often transmitted by expectorate, but can also be transmitted by contact with an infected person, or by virus particles left on objects such as towels and faucet handles. Some people with adenovirus gastroenteritis may shed the virus in their stools for months after getting over the symptoms. The virus can be passed through water in swimming pools that are not sufficiently chlorinated.

As with many other illnesses, good handwashing practice is one way to inhibit the person-to-person transmission of adenoviruses. Heat and bleach will kill adenoviruses on objects.[citation needed]

Treatment[edit]

There are no proven antiviral drugs to treat adenoviral infections, so treatment is largely directed at the symptoms (such as acetaminophen for fever). The antiviral drug cidofovir has helped certain of those patients who had severe cases of illness; the number helped and to what degree, and the particular complications or symptoms it helped with, and when and where this happened, were not given in the source.[35] A doctor may give antibiotic eyedrops for conjunctivitis, while awaiting results of bacterial cultures, and to help prevent secondary bacterial infections. Currently, there is no adenovirus vaccine available to the general public, but a vaccine is available for the United States military for Types 4 and 7.

Use in gene therapy and vaccination[edit]

Gene therapy[edit]

Adenoviruses have long been a popular viral vector for gene therapy due to their ability to affect both replicating and non-replicating cells, accommodate large transgenes, and code for proteins without integrating into the host cell genome.[36] More specifically, they are used as a vehicle to administer targeted therapy,[37] in the form of recombinant DNA or protein. This therapy has been found especially useful in treating monogenic disease (e.g. cystic fibrosis, X-linked SCID, alpha1-antitrypsin deficiency) and cancer.[36] In China, oncolytic adenovirus is an approved cancer treatment.[38] Specific modifications on fibre proteins are used to target Adenovirus to certain cell types;[39] a major effort is made to limit hepatotoxicity and prevent multiple organ failure. Adenovirus dodecahedron can qualify as a potent delivery platform for foreign antigens to human myeloid dendritic cells (MDC), and that it is efficiently presented by MDC to M1-specific CD8+ T lymphocytes.[40]

Adenovirus has been used for delivery of CRISPR/Cas9 gene editing systems, but high immune reactivity to viral infection has posed challenges in use for patients.

Vaccines[edit]

Modified (recombinant) adenovirus vectors, including replication incompetent types, theoretically can deliver DNA coding for specific antigens, but as of May 2020 the technology had "yet to yield an effective vaccine for humans".[41]

Recombinant adenovirus type-5 (Ad5) (Ad5-nCoV,[42] ImmunityBio, UQ-CSL V451) and adenovirus type-26 (Ad26) (Ad26.COV2.S) are being used in candidate COVID-19 vaccines.[43] The Gam-COVID-Vac (aka Sputnik-5) product is innovative because an Ad26 based vaccine is used on the first day and an Ad5 vaccine is used on day 21.[43] "In four candidate COVID-19 vaccines... Ad5... serves as the 'vector' to [transport] the surface protein gene of SARS-CoV-2".[44] The goal is to genetically express the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[citation needed]

A replication-deficient chimpanzee adenovirus vaccine vector (ChAdOx1) is being used in a trial of a COVID-19 vaccine.[45] The vaccine is known as ChAdOx1 nCoV-19 (Jenner Institute) or AZD1222 (AstraZeneca). Another one is ChAd-SARS-CoV-2-S; the vaccine reportedly prevented mice that were genetically modified to have human ACE2 (hACE2) receptors, presumably receptors that allow virus-entry into the cells, from being infected with SARS-CoV-2.[46][47]

Possible issues with using Adenovirus as vaccine vectors include: the human body develops immunity to the vector itself, making subsequent booster shots difficult or impossible.[48] In some cases, people have pre-existing immunity to Adenoviruses, making vector delivery ineffective.[49]

The use of Ad5 vaccines for COVID-19 worried researchers who had experience with failed trials of an Ad5 vaccine, due to the increased risk for male patients of contracting HIV-1 via unprotected sex.[50] In October 2020, they wrote in The Lancet: "On the basis of these findings, we are concerned that use of an Ad5 vector for immunisation against SARS-CoV-2 could similarly increase the risk of HIV-1 acquisition among men who receive the vaccine."[51][52]
On the other hand, Science's article reported that China had approved a CanSino's Ebola vaccine based on Ad5 vector which was tested in Sierra Leone that had high HIV prevalence making it more likely for such problems to be detected. CanSino's CEO said "we haven't seen anything with the Ebola vaccine" and speculated that HIV susceptibility might be limited to Ad5 vaccines that produced HIV proteins. Also, in a research reported in the Lancet in May, the company's researchers acknowledged the "controversial" possibility, and said they would watch for it in the company's COVID-19 vaccine candidate's trials.[44][42]

See also[edit]

Medicine portal

Viruses portal

VA (viral associated) RNA

References[edit]

^ a b c d e f g h i j k l m n "9.11H: Double-Stranded DNA Viruses- Adenoviruses". Biology LibreTexts. 25 June 2017. Retrieved 6 January 2021.

^ Rowe WP, Huebner RJ, Gilmore LK, Parrott RH, Ward TG (December 1953). "Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture". Proceedings of the Society for Experimental Biology and Medicine. 84 (3): 570–3. doi:10.3181/00379727-84-20714. PMID 13134217. S2CID 3097955.

^ Dhingra, Akshay; Hage, Elias; Ganzenmueller, Tina; Böttcher, Sindy; Hofmann, Jörg; Hamprecht, Klaus; Obermeier, Patrick; Rath, Barbara; Hausmann, Fabian; Dobner, Thomas; Heim, Albert (31 January 2019). "Molecular Evolution of Human Adenovirus (HAdV) Species C". Scientific Reports. 9 (1): 1039. Bibcode:2019NatSR...9.1039D. doi:10.1038/s41598-018-37249-4. ISSN 2045-2322. PMC 6355881. PMID 30705303.

^ Walsh MP, Seto J, Liu EB, Dehghan S, Hudson NR, Lukashev AN, Ivanova O, Chodosh J, Dyer DW, Jones MS, Seto D (October 2011). "Computational analysis of two species C human adenoviruses provides evidence of a novel virus". Journal of Clinical Microbiology. 49 (10): 3482–90. doi:10.1128/JCM.00156-11. PMC 3187342. PMID 21849694.

^ Robinson CM, Singh G, Henquell C, Walsh MP, Peigue-Lafeuille H, Seto D, Jones MS, Dyer DW, Chodosh J (January 2011). "Computational analysis and identification of an emergent human adenovirus pathogen implicated in a respiratory fatality". Virology. 409 (2): 141–7. doi:10.1016/j.virol.2010.10.020. PMC 3006489. PMID 21056888.

^ Singh G, Robinson CM, Dehghan S, Schmidt T, Seto D, Jones MS, Dyer DW, Chodosh J (Feb 2012). "Overreliance on the hexon gene, leading to misclassification of human adenoviruses". Journal of Virology. 86 (8): 4693–5. doi:10.1128/jvi.06969-11. PMC 3318657. PMID 22301156.

^ Singh G, Zhou X, Lee JY, Yousuf MA, Ramke M, Ismail AM, Lee JS, Robinson CM, Seto D, Dyer DW, Jones MS, Rajaiya J, Chodosh J (Nov 2015). "Recombination of the Epsilon Determinant and Corneal Tropism: Human Adenovirus Species D Types 15, 29, 56, and 69". Virology. 485: 452–459. doi:10.1016/j.virol.2015.08.018. PMC 4619159. PMID 26343864.

^ Jones MS, Harrach B, Ganac RD, Gozum MM, Dela Cruz WP, Riedel B, Pan C, Delwart EL, Schnurr DP (June 2007). "New adenovirus species found in a patient presenting with gastroenteritis". Journal of Virology. 81 (11): 5978–84. doi:10.1128/JVI.02650-06. PMC 1900323. PMID 17360747.

^ "Adenovirus | Home | CDC". www.cdc.gov. Centers for Disease control and prevention. 31 January 2020. Retrieved 6 January 2021.

^ Voss JD, Atkinson RL, Dhurandhar NV (November 2015). "Role of adenoviruses in obesity". Reviews in Medical Virology. 25 (6): 379–87. doi:10.1002/rmv.1852. PMID 26352001. S2CID 5370331.

^ Martin, Malcolm A.; Knipe, David M.; Fields, Bernard N.; Howley, Peter M.; Griffin, Diane; Lamb, Robert (2007). Fields' virology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 2395. ISBN 978-0-7817-6060-7.

^ Scientists Unveil Structure of Adenovirus, the Largest High-Resolution Complex Ever Found Science Daily website, retrieved August 30, 2010

^ Harrison SC (August 2010). "Virology. Looking inside adenovirus". Science. 329 (5995): 1026–7. Bibcode:2010Sci...329.1026H. doi:10.1126/science.1194922. PMID 20798308. S2CID 206528739.

^ Wu E, Nemerow GR (April 2004). "Virus yoga: the role of flexibility in virus host cell recognition". Trends in Microbiology. 12 (4): 162–9. doi:10.1016/j.tim.2004.02.005. PMID 15051066.

^ Flint J, Skalka AM, Rall GF, Racaniello VR (2015). Principles of Virology. Volume I: Molecular Biology. doi:10.1128/9781555818951. ISBN 9781555819330.

^ Meier O, Greber UF (February 2004). "Adenovirus endocytosis". The Journal of Gene Medicine. 6 Suppl 1 (Suppl 1): S152-63. doi:10.1002/jgm.553. PMID 14978758. S2CID 22241820.

^ Lee et al. (2017), The characteristics of adenovirus, pp. 47-48 harvp error: no target: CITEREFLeeBishopZhangFarina2017 (help)

^ a b Yamamoto H, Shimojo H (August 1971). "Multiplicity reactivation of human adenovirus type 12 and simian virus 40 irradiated by ultraviolet light". Virology. 45 (2): 529–31. doi:10.1016/0042-6822(71)90355-2. PMID 4328814.

^ Michod RE, Bernstein H, Nedelcu AM (May 2008). "Adaptive value of sex in microbial pathogens" (PDF). Infection, Genetics and Evolution. 8 (3): 267–85. doi:10.1016/j.meegid.2008.01.002. PMID 18295550.

^ Wan, Y. Y.; Leon, R. P.; Marks, R.; Cham, C. M.; Schaack, J.; Gajewski, T. F.; DeGregori, J. (2000). "Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells". Proceedings of the National Academy of Sciences. 97 (25): 13784–13789. doi:10.1073/pnas.250356297. ISSN 0027-8424. PMC 17653. PMID 11095726.

^ Chen LH, Wu ZQ, Hu YF, Yang F, Yang J, Jin Q (June 2012). "[Genetic diversity of adenoviruses in bats of China]". Bing du Xue Bao = Chinese Journal of Virology. 28 (4): 403–8. PMID 22978165.

^ Li Y, Ge X, Zhang H, Zhou P, Zhu Y, Zhang Y, Yuan J, Wang LF, Shi Z (April 2010). "Host range, prevalence, and genetic diversity of adenoviruses in bats". Journal of Virology. 84 (8): 3889–97. doi:10.1128/JVI.02497-09. PMC 2849498. PMID 20089640.

^ a b Fenner, Frank J.; Gibbs, E. Paul J.; Murphy, Frederick A.; Rott, Rudolph; Studdert, Michael J.; White, David O. (1993). Veterinary Virology (2nd ed.). Academic Press, Inc. ISBN 978-0-12-253056-2.

^ Goldstein T, Colegrove KM, Hanson M, Gulland FM (May 2011). "Isolation of a novel adenovirus from California sea lions Zalophus californianus". Diseases of Aquatic Organisms. 94 (3): 243–8. doi:10.3354/dao02321. PMID 21790072.

^ "Inclusion Body Hepatitis and Hepatitis Hydropericardium Syndrome in Poultry - Poultry". Veterinary Manual.

^ Kumar R, Kumar V, Asthana M, Shukla SK, Chandra R (January 2010). "Isolation and identification of a fowl adenovirus from wild Black Kites (Milvus migrans)". Journal of Wildlife Diseases. 46 (1): 272–6. doi:10.7589/0090-3558-46.1.272. PMID 20090043.

^ Chen EC, Yagi S, Kelly KR, Mendoza SP, Tarara RP, Canfield DR, Maninger N, Rosenthal A, Spinner A, Bales KL, Schnurr DP, Lerche NW, Chiu CY (July 2011). Nemerow GR (ed.). "Cross-species transmission of a novel adenovirus associated with a fulminant pneumonia outbreak in a new world monkey colony". PLOS Pathogens. 7 (7): e1002155. doi:10.1371/journal.ppat.1002155. PMC 3136464. PMID 21779173.

^ a b "Adenovirus | Prevention and Treatment | CDC". 2019-09-03.

^ "USAMRMC protects Soldiers against unseen enemy".

^ "Default - Stanford Children's Health".

^ "Adenovirus | Clinical Diagnosis | CDC". 2019-08-29.

^ Wadell G.; et al. (1987). Whelan, Julie; Bock, Gregory (eds.). Novel diarrhoea viruses. New York: Wiley. p. 63. ISBN 978-0-471-91094-7.

^ Amy Burkholder (2007-12-19). "A killer cold? Even the healthy may be vulnerable". CNN. Retrieved 2007-12-19.

^ Hosseini SM, Mirhosseini SM, Taghian M, Salehi M, Farahani MM, Bakhtiari F, Ghasemi-Pirbaluti M, Motaghi E (October 2018). "First evidence of the presence of adenovirus type 8 in myocardium of patients with severe idiopathic dilated cardiomyopathy". Archives of Virology. 163 (10): 2895–2897. doi:10.1007/s00705-018-3942-3. PMID 30022238. S2CID 49870344.

^ Fox M (January 28, 2018). "Adenovirus looks like flu, acts like flu, but it's not influenza". NBC News.

^ a b Lee CS, Bishop ES, Zhang R, Yu X, Farina EM, Yan S, Zhao C, Zheng Z, Shu Y, Wu X, Lei J, Li Y, Zhang W, Yang C, Wu K, Wu Y, Ho S, Athiviraham A, Lee MJ, Wolf JM, Reid RR, He TC (June 2017). "Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine". Genes & Diseases. 4 (2): 43–63. doi:10.1016/j.gendis.2017.04.001. PMC 5609467. PMID 28944281.CS1 maint: date and year (link)

^ Thacker EE, Nakayama M, Smith BF, Bird RC, Muminova Z, Strong TV, Timares L, Korokhov N, O'Neill AM, de Gruijl TD, Glasgow JN, Tani K, Curiel DT (November 2009). "A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo". Vaccine. 27 (50): 7116–24. doi:10.1016/j.vaccine.2009.09.055. PMC 2784276. PMID 19786146.

^ Harrington KJ, Vile RG, Pandha HS, eds. (May 2008). Viral Therapy of Cancer. Hoboken, N.J.: Wiley. pp. 1–13. ISBN 9780470019221.

^ Xin KQ, Sekimoto Y, Takahashi T, Mizuguchi H, Ichino M, Yoshida A, Okuda K (May 2007). "Chimeric adenovirus 5/35 vector containing the clade C HIV gag gene induces a cross-reactive immune response against HIV". Vaccine. 25 (19): 3809–15. doi:10.1016/j.vaccine.2007.01.117. PMID 17386962.

^ Naskalska A, Szolajska E, Chaperot L, Angel J, Plumas J, Chroboczek J (December 2009). "Influenza recombinant vaccine: matrix protein M1 on the platform of the adenovirus dodecahedron". Vaccine. 27 (52): 7385–93. doi:10.1016/j.vaccine.2009.09.021. PMID 19766576.

^ Cross, Ryan (12 May 2020). "Adenoviral vectors are the new COVID-19 vaccine front-runners. Can they overcome their checkered past?". Chemical & Engineering News. 98 (19). Retrieved 15 December 2020.

^ a b Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, et al. (June 2020). "Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial". Lancet. 395 (10240): 1845–1854. doi:10.1016/s0140-6736(20)31208-3. PMC 7255193. PMID 32450106.

^ a b "An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19". Clinical Trials. 22 June 2020. Retrieved 22 December 2020.

^ a b Cohen, Jon (19 October 2020). "Could certain COVID-19 vaccines leave people more vulnerable to the AIDS virus?". American Association for the Advancement of Science. Science (magazine). Retrieved 15 December 2020.

^ Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al. (15 August 2020). "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial". Lancet. 396 (10249): 467–478. doi:10.1016/S0140-6736(20)31604-4. PMC 7445431. PMID 32702298.

^ "Experimental Nasal Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2". Sci News. 27 August 2020. Retrieved 28 August 2020.

^ Hassan AO, Kafai NM, Dmitriev IP, Fox JM, Smith BK, Harvey IB, et al. (1 October 2020). "A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2". Cell. 183 (1): 169–184.e13. doi:10.1016/j.cell.2020.08.026. PMC 7437481. PMID 32931734.

^ Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, et al. (26 September 2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". Lancet. 396 (10255): 887–897. doi:10.1016/S0140-6736(20)31866-3. PMC 7471804. PMID 32896291.

^ Fausther-Bovendo H, Kobinger GP (2014). "Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?". Hum Vaccin Immunother. 10 (10): 2875–8284. doi:10.4161/hv.29594. PMC 5443060. PMID 25483662.

^ Collins, Simon (9 December 2020). "HIV risk from some COVID-19 vaccines might be unlikely due to rarity of vector viruses involved". HIV i-BASE. Retrieved 15 December 2020.

^ Rosenberg, Jaime (25 October 2020). "Researchers Warn of Heightened Risk of HIV With Certain COVID-19 Vaccines". AJMC. Retrieved 15 December 2020.

^ Buchbinder SP, McElrath MJ, Dieffenbach C, Corey L (31 October 2020). "Use of adenovirus type-5 vectored vaccines: a cautionary tale". Lancet. 396 (10260): e68–e69. doi:10.1016/S0140-6736(20)32156-5. PMC 7571904. PMID 33091364.

External links[edit]

Wikimedia Commons has media related to Adenoviridae.

Centers for Disease Control and Prevention—National Center for Diseases—Division of Viral and Rickettsial Diseases, Respiratory and Enteric Viruses Branch

MicrobiologyBytes: Adenoviruses

Stanford University—Adenoviruses

Adenoviruses General Concepts

General information on Adenovirus

DNA virus replication strategies

Sequenced adenoviruses

Kids Health—Adenoviruses

Viralzone: Adenoviridae

Adenovirus Research Discussion Group

USAMRMC protects Soldiers against unseen enemy

3D macromolecular structures of Adenoviruses archived in the EM Data Bank(EMDB)

Molecule of the Month: Adenovirus

ICTV

v

t

e

Common cold

Viruses

Adenovirus

Coronavirus

Enterovirus

Rhinovirus

Symptoms

Cough

Fatigue

Fever

Headache

Loss of appetite

Malaise

Muscle aches

Nasal congestion

Rhinorrhea

Sneezing

Sore throat

Weakness

Complications

Acute bronchitis

Bronchiolitis

Croup

Otitis media

Pharyngitis

Pneumonia

Sinusitis

Strep throat

Drugs

Antiviral drugs

Pleconaril (experimental)

v

t

e

Baltimore (virus classification)

DNA

I: dsDNA viruses

Duplodnaviria

Heunggongvirae

Peploviricota

Herviviricetes

Herpesvirales

Alloherpesviridae

Herpesviridae

Malacoherpesviridae

Uroviricota

Caudoviricetes

Caudovirales

Ackermannviridae

Autographiviridae

Chaseviridae

Demerecviridae

Drexlerviridae

Herelleviridae

Myoviridae

Podoviridae

Siphoviridae

Zobellviridae

Monodnaviria

Shotokuvirae

Cossaviricota

Papovaviricetes

Sepolyvirales

Polyomaviridae

Zurhausenvirales

Papillomaviridae

Varidnaviria

Bamfordvirae

Nucleocytoviricota

Pokkesviricetes

Asfuvirales

Asfarviridae

Chitovirales

Poxviridae

Megaviricetes

Algavirales

Phycodnaviridae

Imitervirales

Mimiviridae

Pimascovirales

Ascoviridae

Iridoviridae

Marseilleviridae

Preplasmiviricota

Maveriviricetes

Priklausovirales

Lavidaviridae

Tectiliviricetes

Belfryvirales

Turriviridae

Kalamavirales

Tectiviridae

Rowavirales

Adenoviridae

Vinavirales

Corticoviridae

Helvetiavirae

Dividnaviricota

Laserviricetes

Halopanivirales

Sphaerolipoviridae

Unassigned

Ligamenvirales

Lipothrixviridae

Rudiviridae

Unassigned

Families: Ampullaviridae

Baculoviridae

Bicaudaviridae

Clavaviridae

Fuselloviridae

Globuloviridae

Guttaviridae

Halspiviridae

Hytrosaviridae

Nimaviridae

Nudiviridae

Ovaliviridae

Plasmaviridae

Polydnaviridae

Portogloboviridae

Thaspiviridae

Tristromaviridae

Genera: Dinodnavirus

Rhizidiovirus

II: ssDNA viruses

Monodnaviria

Loebvirae

Hofneiviricota

Faserviricetes

Tubulavirales

Inoviridae

Plectroviridae

Sangervirae

Phixviricota

Malgrandaviricetes

Petitvirales

Microviridae

Shotokuvirae

Cossaviricota

Mouviricetes

Polivirales

Bidnaviridae

Quintoviricetes

Piccovirales

Parvoviridae

Cressdnaviricota

Arfiviricetes

Baphyvirales

Bacilladnaviridae

Cirlivirales

Circoviridae

Cremevirales

Smacoviridae

Mulpavirales

Nanoviridae

Recrevirales

Redondoviridae

Repensiviricetes

Geplafuvirales

Naminiviridae

Geminiviridae

Genomoviridae

Trapavirae

Saleviricota

Huolimaviricetes

Haloruvirales

Pleolipoviridae

Unassigned

Families: Anelloviridae

Finnlakeviridae

Spiraviridae

RNA

III: dsRNA viruses

Riboviria

Orthornavirae

Duplornaviricota

Chrymotiviricetes

Ghabrivirales

Chrysoviridae

Megabirnaviridae

Quadriviridae

Totiviridae

Resentoviricetes

Reovirales

Reoviridae

Vidaverviricetes

Mindivirales

Cystoviridae

Pisuviricota

Duplopiviricetes

Durnavirales

Amalgaviridae

Hypoviridae

Picobirnaviridae

Partitiviridae

Unassigned

Families: Birnaviridae

Polymycoviridae

Genera: Botybirnavirus

IV: (+)ssRNA viruses (primarily icosahedral)

Riboviria

Orthornavirae

Kitrinoviricota

Alsuviricetes

Hepelivirales

Alphatetraviridae

Benyviridae

Hepeviridae

Matonaviridae

Martellivirales

Bromoviridae

Closteroviridae

Endornaviridae

Kitaviridae

Mayoviridae

Togaviridae

Virgaviridae

Tymovirales

Alphaflexiviridae

Betaflexiviridae

Deltaflexiviridae

Gammaflexiviridae

Tymoviridae

Flasuviricetes

Amarillovirales

Flaviviridae

Magsaviricetes

Nodamuvirales

Nodaviridae

Sinhaliviridae

Tolucaviricetes

Tolivirales

Carmotetraviridae

Luteoviridae

Tombusviridae

Lenarviricota

Allassoviricetes

Levivirales

Leviviridae

Amabiliviricetes

Wolframvirales

Narnaviridae

Howeltoviricetes

Cryppavirales

Mitoviridae

Miaviricetes

Ourlivirales

Botourmiaviridae

Pisuviricota

Pisoniviricetes

Nidovirales

Abyssoviridae

Arteriviridae

Cremegaviridae

Coronaviridae

Euroniviridae

Gresnaviridae

Medioniviridae

Mesoniviridae

Mononiviridae

Nanghoshaviridae

Nanhypoviridae

Olifoviridae

Roniviridae

Tobaniviridae

Picornavirales

Picornaviridae

Marnaviridae

Solinviviridae

Caliciviridae

Iflaviridae

Secoviridae

Dicistroviridae

Polycipiviridae

Sobemovirales

Alvernaviridae

Barnaviridae

Solemoviridae

Stelpaviricetes

Patatavirales

Potyviridae

Stellavirales

Astroviridae

Unassigned

Families: Permutotetraviridae

Sarthroviridae

V: (–)ssRNA viruses (primarily helical)

Riboviria

Orthornavirae

Negarnaviricota

Chunqiuviricetes

Muvirales

Qinviridae

Ellioviricetes

Bunyavirales

Cruliviridae

Arenaviridae

Fimoviridae

Hantaviridae

Leishbuviridae

Mypoviridae

Nairoviridae

Peribunyaviridae

Phasmaviridae

Phenuiviridae

Tospoviridae

Wupedeviridae

Insthoviricetes

Articulavirales

Amnoonviridae

Orthomyxoviridae

Milneviricetes

Serpentovirales

Aspiviridae

Monjiviricetes

Jingchuvirales

Chuviridae

Mononegavirales

Artoviridae

Bornaviridae

Filoviridae

Lispiviridae

Mymonaviridae

Nyamiviridae

Paramyxoviridae

Pneumoviridae

Rhabdoviridae

Sunviridae

Xinmoviridae

Yunchangviricetes

Goujianvirales

Yueviridae

Unassigned

Genera: Deltavirus

RT

VI: ssRNA-RT viruses

Riboviria

Pararnavirae

Artverviricota

Revtraviricetes

Ortervirales

Belpaoviridae

Metaviridae

Pseudoviridae

Retroviridae

VII: dsDNA-RT viruses

Riboviria

Pararnavirae

Artverviricota

Revtraviricetes

Blubervirales

Hepadnaviridae

Ortervirales

Caulimoviridae

v

t

e

Infectious diseases – viral systemic diseases

Oncovirus

DNA virus

HBV

Hepatocellular carcinoma

HPV

Cervical cancer

Anal cancer

Penile cancer

Vulvar cancer

Vaginal cancer

Oropharyngeal cancer

KSHV

Kaposi's sarcoma

EBV

Nasopharyngeal carcinoma

Burkitt's lymphoma

Hodgkin lymphoma

Follicular dendritic cell sarcoma

Extranodal NK/T-cell lymphoma, nasal type

MCPyV

Merkel-cell carcinoma

RNA virus

HCV

Hepatocellular carcinoma

Splenic marginal zone lymphoma

HTLV-I

Adult T-cell leukemia/lymphoma

Immune disorders

HIV

AIDS

Central
nervous system

Encephalitis/
meningitis

DNA virus

Human polyomavirus 2

Progressive multifocal leukoencephalopathy

RNA virus

MeV

Subacute sclerosing panencephalitis

LCV

Lymphocytic choriomeningitis

Arbovirus encephalitis

Orthomyxoviridae (probable)

Encephalitis lethargica

RV

Rabies

Chandipura vesiculovirus

Herpesviral meningitis

Ramsay Hunt syndrome type 2

Myelitis

Poliovirus

Poliomyelitis

Post-polio syndrome

HTLV-I

Tropical spastic paraparesis

Eye

Cytomegalovirus

Cytomegalovirus retinitis

HSV

Herpes of the eye

Cardiovascular

CBV

Pericarditis

Myocarditis

Respiratory system/
acute viral
nasopharyngitis/
viral pneumonia

DNA virus

Epstein–Barr virus

EBV infection/Infectious mononucleosis

Cytomegalovirus

RNA virus

IV: Human coronavirus 229E/NL63/HKU1/OC43

Common cold

MERS coronavirus

Middle East respiratory syndrome

SARS coronavirus

Severe acute respiratory syndrome

SARS coronavirus 2

Coronavirus disease 2019

V, Orthomyxoviridae: Influenza virus A/B/C/D

Influenza/Avian influenza

V, Paramyxoviridae: Human parainfluenza viruses

Parainfluenza

Human orthopneumovirus

hMPV

Human
digestive system

Pharynx/Esophagus

MuV

Mumps

Cytomegalovirus

Cytomegalovirus esophagitis

Gastroenteritis/
diarrhea

DNA virus

Adenovirus

Adenovirus infection

RNA virus

Rotavirus

Norovirus

Astrovirus

Coronavirus

Hepatitis

DNA virus

HBV (B)

RNA virus

CBV

HAV (A)

HCV (C)

HDV (D)

HEV (E)

HGV (G)

Pancreatitis

CBV

Urogenital

BK virus

MuV

Mumps

Taxon identifiers

Wikidata: Q193447

Wikispecies: Adenoviridae

BioLib: 44252

EoL: 5048

GBIF: 6231

IRMNG: 113665

NCBI: 10508

uBio: 1883639

Medicine portal

Viruses portal

Retrieved from "https://en.wikipedia.org/w/index.php?title=Adenoviridae&oldid=1008438576"

Categories:

Adenoviridae

Virus families

Hidden categories:

CS1: long volume value

Harv and Sfn no-target errors

CS1 maint: date and year

Articles with 'species' microformats

Articles to be merged from December 2020

All articles to be merged

Wikipedia articles needing clarification from January 2021

Wikipedia articles needing clarification from February 2021

All articles with unsourced statements

Articles with unsourced statements from February 2021

All articles with dead external links

Articles with dead external links from February 2021

Articles with permanently dead external links

Articles with unsourced statements from March 2019

Articles with unsourced statements from December 2020

Commons category link from Wikidata

Navigation menu

Personal tools

Not logged in

Talk

Contributions

Create account

Log in

Namespaces

Article

Talk

Variants

Views

Read

Edit

View history

More

Search

Navigation

Main page

Contents

Current events

Random article

About Wikipedia

Contact us

Donate

Contribute

Help

Learn to edit

Community portal

Recent changes

Upload file

Tools

What links here

Related changes

Upload file

Special pages

Permanent link

Page information

Cite this page

Wikidata item

Print/export

Download as PDF

Printable version

In other projects

Wikimedia Commons

Wikispecies

Languages

العربية

Azərbaycanca

تۆرکجه

Беларуская

Català

Čeština

Dansk

Deutsch

Eesti

Ελληνικά

Español

Euskara

فارسی

Français

Galego

한국어

Հայերեն

हिन्दी

Hrvatski

Bahasa Indonesia

Italiano

עברית

ಕನ್ನಡ

ქართული

Қазақша

Latina

Magyar

Bahasa Melayu

Nederlands

日本語

Norsk bokmål

Norsk nynorsk

Oʻzbekcha/ўзбекча

Polski

Português

Română

Русский

Slovenčina

Slovenščina

Soomaaliga

Српски / srpski

Srpskohrvatski / српскохрватски

Suomi

Svenska

ไทย

Тоҷикӣ

Türkçe

Українська

Tiếng Việt

粵語

中文

Edit links

This page was last edited on 23 February 2021, at 08:47 (UTC).

Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.

Privacy policy

About Wikipedia

Disclaimers

Contact Wikipedia

Mobile view

Developers

Statistics

Cookie statement